According to Reuters, British scientists suggest a compound derived from marijuana can treat patients at risk of psychosis.
Conducted at King’s College London, researchers used the chemical cannabidiol to treat people with psychotic symptoms without a diagnosis.
MRI scans showed that people with psychotic symptoms who received the compound CBD had less abnormal brain activity in areas associated with psychosis.